Article de revue scientifique Avec comité de lecture
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
Clinical and experimental rheumatology, Vol.30(5), p.756-64
09/2012
PMID: 22766000
Résumé
Antirheumatic Agents Arthritis, Rheumatoid Registries Risk Assessment Risk Factors Skin Neoplasms Time Factors Tumor Necrosis Factor-alpha Chi-Square Distribution Humans Incidence Odds Ratio
To assess the risk of malignancy in patients with rheumatoid arthritis (RA) receiving tumour necrosis factor (TNF) antagonists through a meta-analysis of data from registry studies and systematic review of long-term extension (LTE) studies.
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
Créateurs - sans rôle
Pierre Le Blay - Charmo University
Gaël Mouterde - Hôpital Lapeyronie
Thomas Barnetche - Centre Hospitalier Universitaire de Bordeaux
Jacques Morel - Charmo University
Bernard Combe - Charmo University
Détails de publication
Clinical and experimental rheumatology, Vol.30(5), p.756-64
Identifiants
9944169309311
Unité académique
Institut de Génétique Moléculaire de Montpellier - IGMM